Thrombolytic therapy for submassive/intermediate risk Pulmonary Embolism Evidence and suggestions after PEITHO trial

被引:1
|
作者
Marin V., Arnaldo [1 ]
Tomas Gazmuri B., Jose [2 ]
Andresen V., Max [4 ]
Andresen, Max [3 ]
机构
[1] Univ Chile, Fac Med, Hosp Clin Univ Chile, Med Interna, Santiago 7, Chile
[2] Univ Los Andes, Fac Med, Med Interna, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Fac Med, Interno Med, Santiago, Chile
关键词
Pulmonary embolism; Shock; Thrombectomy; Thrombolytic therapy; RIGHT-VENTRICULAR DYSFUNCTION; TISSUE PLASMINOGEN-ACTIVATOR; MULTICENTER DOUBLE-BLIND; INTRACRANIAL HEMORRHAGE; PROGNOSTIC VALUE; MANAGEMENT; ALTEPLASE; OUTCOMES; HEPARIN; TENECTEPLASE;
D O I
10.4067/S0034-98872015000700011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Therapy for submassive pulmonary embolism (intermediate risk), remains controversial. New evidence has appeared that may help us in the process of decision making. We review the relevant literature, outline prognostic factors, and discuss current recommendations and controversies regarding the available alternatives such as systemic and catheter-directed thrombolytic use.
引用
收藏
页码:895 / 904
页数:10
相关论文
共 50 条
  • [21] Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
    Anna C. Mavromanoli
    Stefano Barco
    Walter Ageno
    Hélène Bouvaist
    Marianne Brodmann
    Claudio Cuccia
    Francis Couturaud
    Claudia Dellas
    Konstantinos Dimopoulos
    Daniel Duerschmied
    Klaus Empen
    Pompilio Faggiano
    Emile Ferrari
    Nazzareno Galiè
    Marcello Galvani
    Alexandre Ghuysen
    George Giannakoulas
    Menno V. Huisman
    David Jiménez
    Matija Kozak
    Irene M. Lang
    Nicolas Meneveau
    Thomas Münzel
    Massimiliano Palazzini
    Antoniu Octavian Petris
    Giancarlo Piovaccari
    Aldo Salvi
    Sebastian Schellong
    Kai-Helge Schmidt
    Franck Verschuren
    Irene Schmidtmann
    Gerrit Toenges
    Frederikus A. Klok
    Stavros V. Konstantinides
    Clinical Research in Cardiology, 2023, 112 : 1372 - 1381
  • [22] Thrombolytic therapy for pulmonary embolism
    Hao, Qiukui
    Dong, Bi Rong
    Yue, Jirong
    Wu, Taixiang
    Liu, Guan J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09):
  • [23] Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism
    Surgit, Ozgur
    Guner, Ahmet
    Turkmen, Irem
    Kahraman, Serkan
    Serbest, Nail Guven
    Guener, Ezgi Gultekin
    Uzun, Fatih
    Erturk, Mehmet
    Yildiz, Mustafa
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2023, 29 (06): : 677 - 684
  • [24] Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks
    Rothschild, Daniel P.
    Goldstein, James A.
    Bowers, Terry R.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (03) : 506 - 510
  • [25] Ultrasound Accelerated Thrombolysis May Be an Effective and Safe Treatment Modality for Intermediate Risk/Submassive Pulmonary Embolism
    Ozmen, Caglar
    Deniz, Ali
    Akilli, Rabia Eker
    Deveci, Onur Sinan
    Cagliyan, Caglar Emre
    Aktas, Hahl
    Celik, Aziz Inan
    Akpinar, Ayca Acikalin
    Disel, Nezihat Rana
    Balli, Huseyin Tugsan
    Hanta, Ismail
    Demir, Mesut
    Usal, Ayhan
    Kanadasi, Mehmet
    INTERNATIONAL HEART JOURNAL, 2016, 57 (01) : 91 - 95
  • [26] Clinical Controversies in Thrombolytic Therapy for the Management of Acute Pulmonary Embolism
    Daley, Mitchell J.
    Lat, Ishaq
    PHARMACOTHERAPY, 2012, 32 (02): : 158 - 172
  • [27] Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism
    Falsetti, Lorenzo
    Marra, Alberto Maria
    Zaccone, Vincenzo
    Sampaolesi, Mattia
    Riccomi, Francesca
    Giovenali, Laura
    Guerrieri, Emanuele
    Viticchi, Giovanna
    D'Agostino, Anna
    Gentili, Tamira
    Nitti, Cinzia
    Moroncini, Gianluca
    Cittadini, Antonio
    Salvi, Aldo
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (05) : 1287 - 1299
  • [28] Safety and Effectiveness of Thrombolytic Therapy Compared with Standard Anticoagulation in Subjects with Submassive Pulmonary Embolism
    Cimen, Pinar
    Alizoroglu, Dursun
    Unlu, Mehmet
    Kirakli, Cenk
    Ediboglu, Ozlem
    Erbaycu, Ahmet Emin
    ERCIYES MEDICAL JOURNAL, 2019, 41 (02) : 175 - 179
  • [29] Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
    Marti, Christophe
    John, Gregor
    Konstantinides, Stavros
    Combescure, Christophe
    Sanchez, Olivier
    Lankeit, Mareike
    Meyer, Guy
    Perrier, Arnaud
    EUROPEAN HEART JOURNAL, 2015, 36 (10) : 605 - 614
  • [30] Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism A Randomized Trial
    Barrios, Deisy
    Duran, Diego
    Rodriguez, Carmen
    Moises, Jorge
    Retegui, Ana
    Lobo, Jose Luis
    Lopez, Raquel
    Chasco, Leyre
    Jara-Palomares, Luis
    Muriel, Alfonso
    Otero-Candelera, Remedios
    Ruiz-Artacho, Pedro
    Monreal, Manuel
    Bikdeli, Behnood
    Jimenez, David
    CHEST, 2024, 165 (03) : 673 - 681